The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Injections, Subcutaneous

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Injections, Subcutaneous.
Olatoyosi Odenike
Connection Strength
0.237
Injections, Subcutaneous
  1. A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis. Blood Adv. 2024 Nov 26; 8(22):5735-5743.
    View in: PubMed
    Score: 0.237
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.